Food and Drug Administration Commissioner Scott Gottlieb will return to the conservative American Enterprise Institute think tank after leaving the government on Friday.

Gottlieb, 46, will focus on drug pricing policy, an area he worked to address as FDA commissioner and a top concern among voters. His new role was first reported in the Washington Post, and AEI did not immediately respond to a request for comment.